Asia Pacific ViewPoint - Digital Disruption: Pharmaceuticals and Life Sciences – How innovation is reshaping work, the workforce and the workplace March 2017
What if you could put a lab directly into a human body? What if you could design drugs that target specific diseases with minimal side effects? What if you could create a miniature lab that replicated a human organ? These fascinating “what ifs” are fast becoming reality in the rapidly changing industry of pharmaceuticals and life sciences.
It is a transformation that is occuring against a backdrop of increased competition from generic rivals, funding challenges for small market targeted “smart” drugs and the decline of “rainmaker” blockbuster drugs.
The convergence of the life and physical sciences with engineering, computer science and biotechnology is attracting a new breed of worker to the industry and dramatically changing the type and process of work.
These changes demand an urgent rethink of traditional workplace and real estate solutions – one that CBRE Research foresees will drive the creation of new kinds of workspaces that bring together diverse fields and expertise as pharmaceuticals companies partner with start-ups, universities and even their competitors.